
Albemarle is now a focused lithium and bromine pure-play, following the divestiture of its catalyst business and balance sheet improvements. ALB holds world-class lithium assets, securing a low-cost position and structural advantages, with a robust balance sheet and $2.7 billion in liquidity. The current lithium price recovery and disciplined supply underpin a base case EBITDA of ~$2.5 billion, with further upside from Kings Mountain and DLE expansion.










